mainbody.htm
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
____________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): January 31,
2008
Skinvisible,
Inc.
(Exact
name of registrant as specified in its charter)
|
Nevada
|
000-25911
|
88-0344219
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
|
6320
South Sandhill
Road Suite 10 , Las Vegas, NV
|
89120
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: 702-433-7154
|
___________________________________________________
(Former
name or former address, if changed since last
report)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
[
] Written communications pursuant to
Rule 425 under the Securities Act (17CFR 230.425)
[
] Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
[
] Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[
] Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
SECTION
5 – Corporate Governance and Management
|
Item
5.02
|
Departure
of Directors or Principal Officers; Election of Directors; Appointment
of
Principal Officers
|
Effective
January 31, 2008, Mr. Jost Steinbruchel resigned as a member of our board of
directors. There was no known disagreement with Jost Steinbruchel on
any matter relating to the Company’s operations, policies or
practices.
On
January 31, 2008, Mr. Brian Piwek was appointed to serve as a member of the
Company’s board of directors to fill the vacancy left by Mr. Jost
Steinbruchel.
Mr.
Piwek's was the president of Overwaitea Foods
supermarket from 1991 until 1997. In 1997 he accepted the position
as Co-CEO with A&P Canada (The Great Atlantic & Pacific Tea Company
Inc.) and in 2000 was appointed Chairman, President and CEO of A&P
Canada. In late 2002 he moved to the United States as President and Chief
Executive Officer of A&P US (New York Stock Exchange symbol "GAP") where he
began the turnaround of Norht America's oldest retail food chain. Mr.
Piwek retired from A&P in July 2005 and has been recognized for his
achievements throughout his career including "President of the Year" by the
Jim
Pattison Group for the oustanding financial performance of Overwaitea in
1993. Mr. Piwek is an MBA graduate and has served on many voluntary
boards.
SECTION
7–
Regulation FD
|
Item
7.01
|
Regulation
FD Disclosure
|
On
January 30, 2008 the Company signed an exclusive licensing agreement with
Panalab Internacional S. A. for the right to develop and commercialize the
Company’s prescription anti-acne products formulated with adapalene and
Invisicare® in Argentina, Brazil and Chile.
The
information in this Item 7.01 of Form 8-K is “furnished” and not “filed” for the
purposes of Section 18 of the Exchange Act or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference
in
any filing under the Securities Act of 1933 or the Exchange Act of 1934, except
as expressly set forth by specific reference in such filing.
These
projections and assumptions contain forward-looking statements within the
meaning of Section 27A of the Securities Act, and Section 21E of the Securities
Exchange Act of 1934, as amended. These forward-looking statements are subject
to risks and uncertainties that could cause actual results to differ materially
from those projected. Further information on factors that could affect the
Company’s financial and other results is set forth in the projections and
assumptions and included in the Company’s Forms 10-QSB and 10-KSB, filed with
the Securities and Exchange Commission.
SECTION
9 – Financial Statements and Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Skinvisible,
Inc.
/s/
Terry Howlett
Terry
Howlett
Chief
Executive Officer
Date: January
31,
2008